ions.bio
ions.bio provides integrated, AI-driven biomarker discovery and validation solutions for diagnostics and drug development using advanced mass spectrometry and data analysis.
About
ions.bio is a biotech start-up based in the Munich biotech cluster in Martinsried, Germany, focused on leading the biomarker transformation of the health care industry. Their mission is to uncover actionable biomarkers that drive the future of diagnostics and therapeutic development leveraging a proprietary mass spectrometry platform and advanced AI-powered bioinformatic analysis. ions.bio covers the entire biomarker discovery value chain, from clinical sample collection and data generation (proteomics, lipidomics, metabolomics) to AI-driven data analysis, biomarker validation, and translation into high-throughput assays. The company actively collaborates with biotech and pharmaceutical industry partners, supporting diagnostics acceleration and clinical trial patient stratification for more precise, personalized medicine. Their team consists of leading scientists, AI enthusiasts, and serial entrepreneurs with a strong academic record.
Products & Services
- End-to-end biomarker discovery and validation
- Clinical sample collection and processing
- Mass spectrometry-based multi-omics data acquisition (proteomics, lipidomics, metabolomics)
- AI-powered bioinformatics and statistical data analysis
- Biomarker discovery engine with proprietary software
- Biomarker validation with large cohorts and in-house knowledge base
- Conversion of validated biomarkers into ready-to-use assays
- Pharmacodynamic biomarker services for drug development
- Patient stratification for clinical trials
Use Cases & Case Studies
-
Partnerships & Collaborations
- University Hospital Bonn (UKBonn)
- LAMPseq
- Technical University of Munich (TUM)
Awards & Recognition
-